nach oben

Medical Oncology

Erschienen in:

01.01.2019 | Review Article

Multidisciplinary team in head and neck cancer: a management model

verfasst von: F. De Felice, V. Tombolini, M. de Vincentiis, G. Magliulo, A. Greco, V. Valentini, A. Polimeni

Erschienen in: Medical Oncology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Nowadays, the multidisciplinary team (MDT) is an essential component for oncologic disease management. Its benefit is also extensively recognized in head and neck cancer (HNC) community, due to tumor rarity and complex treatment. A well-defined MDT management serves as a stable point to define the better strategy and offers a chance to optimize HNC clinical outcomes and patient’s quality of life. We explored both mandatory and additional requirements for establishing a high-quality MDT. Then we proposed an example of HNC MDT organization. The aim is to contribute to the best way to systematize HNC care.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68(1):7–30.CrossRef

AIOM. AIRTUM. I numeri del cancro in Italia. Il Pensiero Scientifico. 2016.

Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, Silverman CL, Raben A, Kim HE, Horwitz EM, Read NE, Harris J, Wu Q, Le QT, Gillison ML. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol. 2015;33(2):156–64.CrossRef

Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24(14):2137–50.CrossRef

Lydiatt WM, Patel SG, O’Sullivan B, Brandwein MS, Ridge JA, Migliacci JC, Loomis AM, Shah JP. Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37.CrossRef

https://www.ahrq.gov.

De Felice F, Polimeni A, Valentini V, Brugnoletti O, Cassoni A, Greco A, de Vincentiis M, Tombolini V. Radiotherapy controversies and prospective in head and neck cancer: a literature-based critical review. Neoplasia. 2018;20(3):227–32.CrossRef

National Comprehensive Cancer Network (NCCN). Guidelines Head and Neck Cancers, Version 2.2018. http://www.nccn.org. Accessed 9 Sept 2018.

http://www.ehns.org. Accessed 9 Sept 2018.

10.

Harris JR, Lau H, Surgeoner BV, Chua N, Dobrovolsky W, Dort JC, Kalaydjian E, Nesbitt M, Scrimger RA, Seikaly H, Skarsgard D, Webster MA. Members of the Alberta Provincial Head and Neck Tumour Team. Health care delivery for head-and-neck cancer patients in Alberta: a practice guideline. Curr Oncol. 2014;21(5):e704–14.CrossRef

11.

Penel N, Valentin F, Giscard S, Vanseymortier L, Beuscart R. General practitioners assessment of a structured report on medical decision making by a regional multidisciplinary cancer committee. Bull Cancer. 2007;94(10):E23–6.

12.

https://www.ecco-org.eu. Accessed 9 Sept 2018.

13.

http://www.aiocc.it. Accessed 9 Sept 2018.

14.

http://www.shanghairanking.com. Accessed 9 Sept 2018.

15.

De Felice F, de Vincentiis M, Valentini V, Musio D, Mezi S, Lo Mele L, Terenzi V, D’Aguanno V, Cassoni A, Di Brino M, Tenore G, Bulzonetti N, Battisti A, Greco A, Pompa G, Minni A, Romeo U, Cortesi E, Polimeni A, Tombolini V. Follow-up program in head and neck cancer. Crit Rev Oncol Hematol. 2017;113:151–5.CrossRef

16.

De Felice F, de Vincentiis M, Valentini V, Musio D, Mezi S, Lo Mele L, Della Monaca M, D’Aguanno V, Terenzi V, Di Brino M, Brauner E, Bulzonetti N, Tenore G, Pomati G, Cassoni A, Tombolini M, Battisti A, Greco A, Pompa G, Minni A, Romeo U, Cortesi E, Polimeni A, Tombolini V. Management of salivary gland malignant tumor: the Policlinico Umberto I, “Sapienza” University of Rome Head and Neck Unit clinical recommendations. Crit Rev Oncol Hematol. 2017;120:93–7.CrossRef

17.

Zeliotis C. Where to next for cancer centre design? Fut Healthcare J. 2017;4(2):142–5.

18.

De Felice F, Thomas C, Patel V, Connor S, Michaelidou A, Sproat C, Kwok J, Burke M, Reilly D, McGurk M, Simo R, Lyons A, Oakley R, Jeannon JP, Lei M, Urbano TG. Osteoradionecrosis following treatment for head and neck cancer and the effect of radiotherapy dosimetry: the Guy’s and St Thomas’ Head and Neck Cancer Unit experience. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(1):28–34.CrossRef

Titel: Multidisciplinary team in head and neck cancer: a management model
verfasst von: F. De Felice
V. Tombolini
M. de Vincentiis
G. Magliulo
A. Greco
V. Valentini
A. Polimeni
Publikationsdatum: 01.01.2019
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 1/2019
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-018-1227-z

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Multidisciplinary team in head and neck cancer: a management model

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy

Isocitrate dehydrogenase gene mutations and 2-hydroxyglutarate accumulation in esophageal squamous cell carcinoma

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis

Radiotherapy with the anti-programmed cell death ligand-1 immune checkpoint blocker avelumab: acute toxicities in triple-negative breast cancer

Unraveling KDM4 histone demethylase expression and its association with adverse cytogenetic findings in chronic lymphocytic leukemia

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie